Skip to content
No picture yet

Lenvima 24 mg – DIN 02450291

Lenvima is Lenvatinib Mesylate 24 mg (capsule), sold in Canada. It is used for renal cell carcinoma and thyroid neoplasms. It is supplied by Eisai Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Lenvatinib Mesylate 24 mg

Brand
Lenvima
Strength
24 mg
Used for
Renal cell carcinoma and thyroid neoplasms
Form
Capsule
Manufacturer
Eisai Limited
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02450291

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lenvatinib pills and guides

What is Lenvatinib used for?

Lenvatinib is used for renal cell carcinoma and thyroid neoplasms.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Differentiated Thyroid Cancer

LENVIMA is indicated for the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).

Renal Cell Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).

LENVIMA, in combination with everolimus, is indicated for the treatment of adult patients with advanced RCC following one prior anti-angiogenic therapy.

Hepatocellular Carcinoma

LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

Endometrial Carcinoma

LENVIMA, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.

From the FDA-approved label on DailyMed (published Jun 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02450291.
  • It names Lenvima, Lenvatinib Mesylate 24 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Lenvima each 24 mg daily dose contains 2 x 10 mg capsules and 1 x 4 mg capsules per blister by Eisai Limited.

In Canada: prescription only.

Ingredients

Active: Lenvatinib (Lenvatinib Mesylate)

Other Lenvatinib pills